基本信息
浏览量:1
职业迁徙
个人简介
Our research program is aimed at understanding the genetic program that underlies the pathogenesis of glioblastoma, the most prevalent and malignant form of brain cancer. Applying a combination of cell/molecular biology, oncogenomic, and mouse engineering approaches, we systematically characterize novel glioma-relevant oncogenes and tumor suppressors with important roles in glioma cell survival and metabolism. In addition, my laboratory seeks to understand fundamental mechanisms of tumor-mediated immune suppression and to develop novel nanotechnology-enabled approaches directed against actionable immune targets. My group is known for its bench-to-beside efforts to drive nanotechnologies toward clinical opportunity. These efforts have resulted in the first in-human clinical trial of gene-regulatory spherical nucleic acids (SNAs) for the treatment of recurrent glioblastoma.
研究兴趣
论文共 77 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Genes & developmentno. 7-8 (2024): 355-355
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAno. 8 (2024): e2306973121-e2306973121
crossref(2023)
crossref(2023)
crossref(2023)
Antioxidants & redox signalingno. 13-15 (2023): 923-941
加载更多
作者统计
#Papers: 78
#Citation: 8067
H-Index: 34
G-Index: 52
Sociability: 7
Diversity: 3
Activity: 14
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn